| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President And COO
1 company
Metzger Michael A is a Chief Executive Officer at Syndax Pharmaceuticals Inc. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $9.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2022 | SNDX Syndax Pharmaceuticals Inc | Chief Executive Officer | Sale+OE | 15,109 | $21.07 | $318,407.17 | -30.0% | +25.1% | +2.7% | |
| Dec 20, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 85,391 | $19.94 | $1,702,845.11 | -54.7% | -19.8% | +12.2% | |
| Dec 13, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 36,609 | $19.05 | $697,518.60 | -50.9% | -12.9% | +37.1% | |
| Oct 26, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 61,000 | $19.15 | $1,168,159.58 | -63.3% | -12.1% | +21.3% | |
| Sep 27, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 24,437 | $19.51 | $476,831.85 | -58.1% | +11.1% | +18.2% | |
| Sep 22, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 36,563 | $19.22 | $702,860.66 | -40.8% | +12.9% | +21.2% | |
| Sep 14, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 61,000 | $19.12 | $1,166,032.97 | -63.3% | -4.7% | +25.6% | |
| Feb 1, 2021 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 15,000 | $20.19 | $302,799.00 | -45.9% | - | - | |
| Dec 1, 2020 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 15,000 | $22.97 | $344,512.50 | -45.9% | - | - | |
| Nov 4, 2020 | SNDX Syndax Pharmaceuticals Inc | President And COO | Sale+OE | 100,000 | $20.31 | $2,031,410.00 | -85.0% | - | - |